US Stock MarketDetailed Quotes

CRVS Corvus Pharmaceuticals

Watchlist
  • 4.700
  • -2.690-36.40%
Close Dec 18 16:00 ET
  • 4.550
  • -0.150-3.19%
Pre 07:09 ET
302.01MMarket Cap-4.75P/E (TTM)

Corvus Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Corvus Pharmaceuticals Q3 2024 Earnings Date

Currency：USDNov 12, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
0
0
0
--
--
--
EPS
-0.12
-0.60
-0.48
Miss Est.
+3.34%
-400.00%
-417.69%
Analyst Rating
Strong Buy

Dec 19, 2024

Corvus Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
Nov 12, 20242024/Q30.000 / 0.000--
Aug 6, 20242024/Q20.000 / 0.000--
May 6, 20242024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
Nov 12, 20242024/Q30.000 / 0.000--
Aug 6, 20242024/Q20.000 / 0.000--
May 6, 20242024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Corvus Pharmaceuticals Earnings Reports

  • Corvus Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Nov 12 16:12 ET

  • Corvus Pharmaceuticals | 8-K: Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2024 Financial Results

    Nov 12 16:09 ET

  • Corvus Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 6 16:07 ET

  • Corvus Pharmaceuticals | 8-K: Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2024 Financial Results

    Aug 6 16:05 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 19, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data